Insights On Drug Development

  1. Addressing Raw Material Handling Challenges By Dry Granulation 8/12/2025

    Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.

  2. How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions 8/11/2025

    With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence

  3. Facilitate Handling Of Bulk Powders With Dry Granulation 8/11/2025

    Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.

  4. The Rise Of Targeted Modalities In Pharmaceutical Development 8/11/2025

    Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.

  5. Targeted Modalities: Trends, Challenges, CDMO Considerations 8/11/2025

    Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.

  6. Particles In High Concentration Biotherapeutics 8/7/2025

    Examine advanced analytical solutions that detect, characterize, and mitigate particle formation in high-concentration biotherapeutics caused by protein aggregation and surfactant degradation.

  7. Considerations For Subcutaneous, Intramuscular Formulation Development 8/7/2025

    Explore the changing landscape of parenteral delivery, considering the pros and cons of intravenous, subcutaneous, and intramuscular formulations, and how new technologies are reshaping drug delivery.

  8. Simplifying Antibody-Drug Conjugate Payload Synthesis 8/5/2025

    ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.

  9. Site-Specific Conjugation For Next-Gen ADCs 8/4/2025

    Unlock the full potential of your ADCs with a site-specific conjugation platform that delivers unmatched stability, homogeneity, and therapeutic performance.

  10. Optimizing Cell Therapy Analytics Through DoE Methodologies 8/4/2025

    Design of Experiment (DoE) methods streamline the development of robust, phase-appropriate potency and functional assays, ensuring testing that supports scalable cell therapy development.